Citigroup Lowers Clorox Price Target to $135, Maintains Neutral Rating

Citigroup has lowered its price target for Clorox (CLX) to $135, a 3.57% decrease from $140. The adjustment was made by analyst Filippo Falorni on July 15, 2025. Despite the change, Citigroup maintains its "Neutral" rating for Clorox. The average target price for Clorox is $143.48, with an upside of 15.55% from the current price of $124.17.

Citigroup has reduced its price target for Clorox (NYSE:CLX) to $135, a 3.57% decrease from the previous target of $140. The adjustment was made by analyst Filippo Falorni on July 15, 2025. Despite the change, Citigroup maintains its "Neutral" rating for Clorox [1].

The average target price for Clorox, as calculated by 17 analysts, stands at $143.48, indicating an average upside of 15.55% from the current price of $124.17 [2]. This average target suggests that analysts expect the stock to rise to $143.48 from its current price.

The reduction in the price target comes amidst a broader review of the beverages, household, and personal care sectors by Citigroup. While the industry is expected to show slightly improved fundamentals compared to the first quarter, the specific factors leading to the reduction in Clorox's target price were not detailed in the report.

Institutional investors and analysts have been closely monitoring Clorox's performance. As of the latest data, Clorox has a consensus rating of "Hold" and a consensus price target of $146.83 [1]. The stock has experienced a 2.5% decline in its trading price, hitting $124.15 on July 15, 2025 [1].

Clorox's latest quarterly earnings report, released on May 5, 2025, showed earnings per share (EPS) of $1.45, missing analysts' consensus estimates of $1.57 by $0.12. The company reported revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion [1]. Despite the earnings miss, Clorox continues to demonstrate operational efficiency, maintaining its gross margin expansion and overall market share.

The company's strong portfolio of trusted brands, coupled with its continued investment in innovation and business transformation, positions Clorox for future growth. However, challenges such as weakened US consumer sentiment and macroeconomic uncertainties have impacted sales negatively [2].

Investors should closely monitor Clorox's performance and the broader industry trends as the company continues to navigate these challenges. The stock's performance may be influenced by factors such as changes in consumer sentiment, macroeconomic conditions, and the company's ability to maintain its operational efficiency.

References:
[1] https://www.marketbeat.com/instant-alerts/citigroup-cuts-clorox-nyseclx-price-target-to-13500-2025-07-15/
[2] https://www.gurufocus.com/news/2977020/clorox-clx-price-target-reduced-by-citi-analyst-clx-stock-news